Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Ovarian Neoplasms 33Fallopian Tube Neoplasms 21Endometrial Neoplasms 17Uterine Cervical Neoplasms 13Colorectal Neoplasms 12Neoplasm Metastasis 10Pancreatic Neoplasms 9Prostatic Neoplasms 8Melanoma 8Lung Neoplasms 8Carcinoma, Renal Cell 7Stomach Neoplasms 6Carcinosarcoma 6Carcinoma, Hepatocellular 6Carcinoma, Transitional Cell 5Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms 5Triple Negative Breast Neoplasms 4Papillomavirus Infections 4Esophageal Neoplasms 4Sarcoma 3Rectal Neoplasms 3Colonic Neoplasms 3Vulvar Neoplasms 2Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Sarcoma, Kaposi 2Pelvic Neoplasms 2

Interventions

Trastuzumab 2Magnetic Resonance Spectroscopy 2tipifarnib 1temsirolimus 1sargramostim 1cabozantinib 1aldesleukin 1Vinorelbine 1Specimen Handling 1Sirolimus 1Nivolumab 1Interleukin-12 Subunit p35 1Interleukin-12 1Fluorodeoxyglucose F18 1FAPI-46 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Medullary × Specimen Handling × Gynecologic × Clear all
NCT04514484 2026-05-28

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

National Cancer Institute (NCI)

Phase 1 Active not recruiting
8 enrolled 32 charts
BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Kaposi, HIV Infections, Carcinoma, Medullary, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡